Not Yet Recruiting
Safety and Immunogenicity of PRO-169 in Patients With Diabetic Macular Edema
NCT07429474
- Conditions
- Anti-drug Antibodies (ADAs), Immunogenicity
- Locations
-
- Asociación para Evitar la Ceguera en México I.A.P Coyoacán, Mexico City, Mexico